Xiaojiao Li

439 total citations
32 papers, 257 citations indexed

About

Xiaojiao Li is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Xiaojiao Li has authored 32 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Xiaojiao Li's work include Biosimilars and Bioanalytical Methods (10 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Pharmaceutical studies and practices (4 papers). Xiaojiao Li is often cited by papers focused on Biosimilars and Bioanalytical Methods (10 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Pharmaceutical studies and practices (4 papers). Xiaojiao Li collaborates with scholars based in China, Hong Kong and Canada. Xiaojiao Li's co-authors include Hong Zhang, Jingrui Liu, Xiaoxue Zhu, Cuiyun Li, Min Wu, Quan‐Sheng Qiu, Ligang Fan, Guiling Chen, Xiao Zhang and Irène Villalta and has published in prestigious journals such as PLANT PHYSIOLOGY, Nanoscale and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Xiaojiao Li

28 papers receiving 252 citations

Peers

Countries citing papers authored by Xiaojiao Li

Since Specialization

Citations

This map shows the geographic impact of Xiaojiao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojiao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojiao Li more than expected).

Fields of papers citing papers by Xiaojiao Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojiao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojiao Li. The network helps show where Xiaojiao Li may publish in the future.

Co-authorship network of co-authors of Xiaojiao Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojiao Li. A scholar is included among the top collaborators of Xiaojiao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojiao Li. Xiaojiao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase I study of HEC73543, an oral FLT3 inhibitor: the effect of food on pharmacokinetics after oral dosing in healthy Chinese volunteers 2025 ·Frontiers in Pharmacology ·Lei Wang, Min Wu, Xiaojiao Li, (unknown), Bing Liu, Ying‐Jun Zhang, Li Deng, (unknown)	2
2	Advances and perspectives in biological control of postharvest fungal decay in citrus fruit utilizing yeast antagonists 2025 ·International Journal of Food Microbiology ·Xiaojiao Li, (unknown), Wenjun Wang, Lili Deng, Shixiang Yao, Jian Ming, Hongyin Zhang, Kaifang Zeng	5
3	Multi-omic analysis provides new insights into the regulatory mechanism of the LED-induced delay of postharvest senescence and yellowing in broccoli 2025 ·Postharvest Biology and Technology ·Zhiqiang Wang, (unknown), (unknown), Wenhui Duan, Xiaojiao Li, Junyan Shi, (unknown), Shuzhi Yuan, (unknown), Xiangbin Xu, Jinhua Zuo, Qing Wang	0
4	A self-powered hydration-monitoring and drug-delivery skin patch for closed-loop treatment of atopic dermatitis 2025 ·Microsystems & Nanoengineering ·Shan Liang, Shiwei Liu, Zhihe Long, Xiaojiao Li, Qian Han, Xiaoying Wei, Lili Xing, Xinyu Xue, Meihua Chen	1
5	Two-dimensional ice-like water adlayers on a mica surface with and without a graphene coating under ambient conditions 2024 ·Nanoscale ·Xiaojiao Li, Ye‐Guang Fang, Qi Bai, Jian Jiang, Xiao Cheng Zeng, Joseph S. Francisco, Chongqin Zhu, Wei‐Hai Fang	1
6	An esophageal stent integrated with wireless battery-free movable photodynamic-therapy unit for targeted tumor treatment 2024 ·Materials Today Bio ·(unknown), (unknown), (unknown), Junyang Chen, Xiaojiao Li, Quan Li, (unknown), Lili Xing, Xinyu Xue, (unknown), Meihua Chen	2
7	Safety and Efficacy of Anti–IL-23 Monoclonal Antibody QX004N for Patients With Psoriasis 2024 ·JAMA Dermatology ·Xiaojiao Li, Bing Li, De‐Ming Yang, Meng Wang, Qianqian Li, (unknown), Min Fang, Jingrui Liu, Hong Zhang, Min Wu, Cuiyun Li, Xiaoxue Zhu, Yanhua Ding, (unknown)	0
8	Global incidence and death estimates of chronic kidney disease due to hypertension from 1990 to 2019, an ecological analysis of the global burden of diseases 2019 study 2023 ·BMC Nephrology ·Yan Liu, Qin He, (unknown), Min Tian, Xiaojiao Li, Xufeng Yao, (unknown), (unknown)	23
9	Safety, pharmacokinetics and pharmacodynamics of a novel γ-aminobutyric acid (GABA) receptor potentiator, HSK3486, in Chinese patients with hepatic impairment 2022 ·Annals of Medicine ·(unknown), Xiaojiao Li, Jingrui Liu, Hong Chen, (unknown), Hong Zhang, (unknown), Cuiyun Li, Xiaoxue Zhu, (unknown), Pangke Yan, Nan Wu, Xiao Liu, Shiping Ma, Xu Wang, Yanhua Ding, Chengluan Xuan	12
10	A Phase I Clinical Study Comparing the Tolerance, Immunogenicity, and Pharmacokinetics of Proposed Biosimilar BAT1806 and Reference Tocilizumab in Healthy Chinese Men 2021 ·Frontiers in Pharmacology ·Hong Zhang, Hong Wang, (unknown), Hong Chen, Jingrui Liu, Cuiyun Li, Xiaoxue Zhu, Xiaojiao Li, Jin‐Chen Yu, Yinbo Zhou, (unknown), Zhaohe Wang, Min Wu, (unknown)	13
11	A phase 1 randomized study compare the pharmacokinetics, safety and immunogenicity of HLX04 to reference bevacizumab sourced from the United States, the European Union, and China in healthy Chinese male volunteers 2021 ·Cancer Chemotherapy and Pharmacology ·Xiaoxue Zhu, (unknown), (unknown), Min Wu, Chen Yu, (unknown), Xiaodi Zhang, (unknown), Xiaojiao Li	7
12	A randomized phase-I pharmacokinetic trial comparing the potential biosimilar tocilizumab (QX003S) with the reference product (Actemra ^® ) in Chinese healthy subjects 2021 ·Annals of Medicine ·Hong Zhang, Xiaojiao Li, Jingrui Liu, Cuiyun Li, Min Wu, Xiaoxue Zhu, (unknown), Min Fang, (unknown)	7
13	A Biosimilarity Study Between QX001S and Ustekinumab in Healthy Chinese Male Subjects 2021 ·Frontiers in Pharmacology ·Lei Gao, Qingmei Li, Hong Zhang, Min Wu, Min Fang, Lizhi Yang, Xiaojiao Li, Jingrui Liu, Cuiyun Li, Hong Chen, Xiaoxue Zhu, (unknown), Mingwei Zhou	7
14	A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of QL1206 to Denosumab Among Chinese Healthy Subjects 2020 ·Frontiers in Pharmacology ·Hong Zhang, Min Wu, Xiaoxue Zhu, Cuiyun Li, Xiaojiao Li, (unknown), (unknown), Quan Liu, Wei Wei, Junqi Niu, Yanhua Ding	10
15	CBL3 and CIPK18 are required for the function of NHX5 and NHX6 in mediating Li+ homeostasis in Arabidopsis 2020 ·Journal of Plant Physiology ·Xiao Zhang, Zhanchao Li, Xiaojiao Li, (unknown), (unknown), Quan‐Sheng Qiu	5
16	Safety and pharmacokinetics of a biosimilar of denosumab (KN012): Phase 1 and bioequivalence study in healthy Chinese subjects 2020 ·Expert Opinion on Investigational Drugs ·Hong Zhang, Cuiyun Li, Jingrui Liu, Min Wu, Xiaojiao Li, Xiaoxue Zhu, Qianqian Li, (unknown), Yanhong Mao, (unknown), Qinglong Jin	6
17	Arabidopsis NHX5 and NHX6 regulate PIN6-mediated auxin homeostasis and growth 2020 ·Journal of Plant Physiology ·Shasha Lv, Lu Wang, Xiao Zhang, Xiaojiao Li, Ligang Fan, (unknown), (unknown), (unknown), Megan G. Sawchuk, Enrico Scarpella, Quan‐Sheng Qiu	8
18	A phase I, randomized, double-blinded, single-dose study evaluating the pharmacokinetic equivalence of the biosimilar IBI305 and bevacizumab in healthy male subjects 2019 ·International Journal of Clinical Pharmacology and Therapeutics ·Hong Zhang, Xiaoxue Zhu, (unknown), Cuiyun Li, Hong Chen, Xiaojiao Li, Min Wu, Jingrui Liu, Guiling Chen, Hui Zhou, Shirui Zheng, (unknown)	10
19	Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects 2018 ·Cancer Chemotherapy and Pharmacology ·Hong Zhang, Qingmei Li, Xiaoxue Zhu, Cuiyun Li, Xiaojiao Li, (unknown), Yue Hu, Guiling Chen, (unknown), Jing Wang, (unknown), (unknown)	15
20	Evaluation of calcipotriol transdermal permeation through pig, rat and mouse skin using liquid chromatography–tandem mass spectrometry 2013 ·Biomedical Chromatography ·Xiaojiao Li, Jing Wang, (unknown), (unknown), Zhang Xue-ju, Yantong Sun, Yan Yang, Jingkai Gu	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact